secwatch.observer — SEC 8-K summary
======================================

Issuer:     Renalytix plc (RNLXY)
CIK:        0001811115
Form:       8-K
Filed at:   2024-04-10T23:59:59+00:00
Accession:  0000950170-24-043336
Event type: debt
Sentiment:  neutral
Materiality: 0.40
Item codes: 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Renalytix repays $1.06M of convertible bonds with ADSs; outstanding principal now $12.72M
--------------------------------------------------------------------------------

- Issued 1,818,081 ADSs (3,636,162 ordinary shares) on April 11, 2024 to settle $1.06M of principal and interest due April 7, 2024.
- Principal remaining on 5.5% convertible bonds due April 2027 reduced by $1.06M to $12.72M.
- New ordinary shares admitted to AIM on April 12, 2024; total voting rights rise to 123,552,349.
- Shares issued without SEC registration under Section 3(a)(9) exemption.
- Repayment covers quarterly installment for period from January 8, 2024 to April 7, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1811115/000095017024043336/0000950170-24-043336-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1811115/000095017024043336/rnlx-20240410.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-043336

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer